Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gorman

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Journal of Biochemical Toxicology|January 1, 1992
Effects of diphenyl ether herbicides on porphyrin accumulation by cultured hepatocytesJ M Jacobs, P R Sinclair, N Gorman, et al.
Diabetes, Obesity & Metabolism|June 13, 2023
Tolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes: A 12-week, randomized, placebo-controlled, Phase 2 study comparing different dose-escalation schemesAditi R Saxena, Juan P Frias, Donal N Gorman, et al.
Toxicology|May 7, 1998
Formation of zinc protoporphyrin in cultured hepatocytes: effects of ferrochelatase inhibition, iron chelation or leadJ M Jacobs, P R Sinclair, J F Sinclair, et al.
Biochemical Pharmacology|July 28, 1999
Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of miceN Gorman, H S Walton, W J Bement, et al.
Biochemical Pharmacology|March 29, 2001
Role of cytochrome P450 1A2 in bilirubin degradation Studies in Cyp1a2 (-/-) mutant miceC Zaccaro, S Sweitzer, S Pipino, et al.
Journal of Clinical Pharmacology|October 15, 2023
Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 DiabetesDaryl J Fediuk, Donal N Gorman, Stephanie-An Stoddard, et al.
Journal of the American Medical Informatics Association : JAMIA|February 22, 2003
A cross-site qualitative study of physician order entryJoan S Ash, Paul N Gorman, Mary Lavelle, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1997
Ascorbic acid deficiency in porphyria cutanea tardaP R Sinclair, N Gorman, S I Shedlofsky, et al.
Physical Therapy|February 4, 2021
Priorities of Hybrid Clinician-Managers: A Qualitative Study of How Managers Balance Clinical Quality Among Competing ResponsibilitiesChristopher J Hoekstra, Joan S Ash, Nicole A Steckler, et al.
Methodological Innovations|April 25, 2022
Modeling variation of clinical team processes with multiple sequence alignmentNathan J Bahr, S Herzberg, W Lambert, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Journal of Biochemical Toxicology|January 1, 1992
Effects of diphenyl ether herbicides on porphyrin accumulation by cultured hepatocytesJ M Jacobs, P R Sinclair, N Gorman, et al.
Diabetes, Obesity & Metabolism|June 13, 2023
Tolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes: A 12-week, randomized, placebo-controlled, Phase 2 study comparing different dose-escalation schemesAditi R Saxena, Juan P Frias, Donal N Gorman, et al.
Toxicology|May 7, 1998
Formation of zinc protoporphyrin in cultured hepatocytes: effects of ferrochelatase inhibition, iron chelation or leadJ M Jacobs, P R Sinclair, J F Sinclair, et al.
Biochemical Pharmacology|July 28, 1999
Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of miceN Gorman, H S Walton, W J Bement, et al.
Biochemical Pharmacology|March 29, 2001
Role of cytochrome P450 1A2 in bilirubin degradation Studies in Cyp1a2 (-/-) mutant miceC Zaccaro, S Sweitzer, S Pipino, et al.
Journal of Clinical Pharmacology|October 15, 2023
Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 DiabetesDaryl J Fediuk, Donal N Gorman, Stephanie-An Stoddard, et al.
Journal of the American Medical Informatics Association : JAMIA|February 22, 2003
A cross-site qualitative study of physician order entryJoan S Ash, Paul N Gorman, Mary Lavelle, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1997
Ascorbic acid deficiency in porphyria cutanea tardaP R Sinclair, N Gorman, S I Shedlofsky, et al.
Physical Therapy|February 4, 2021
Priorities of Hybrid Clinician-Managers: A Qualitative Study of How Managers Balance Clinical Quality Among Competing ResponsibilitiesChristopher J Hoekstra, Joan S Ash, Nicole A Steckler, et al.
Methodological Innovations|April 25, 2022
Modeling variation of clinical team processes with multiple sequence alignmentNathan J Bahr, S Herzberg, W Lambert, et al.
Pageof 11